207 related articles for article (PubMed ID: 2807531)
1. Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs.
Nikaido Y; Yoshida S; Goto Y; Mizuguchi Y; Kuroiwa A
Infect Immun; 1989 Nov; 57(11):3458-65. PubMed ID: 2807531
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.
Blander SJ; Horwitz MA
J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324
[TBL] [Abstract][Full Text] [Related]
3. Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens.
Breiman RF; Horwitz MA
J Exp Med; 1987 Mar; 165(3):799-811. PubMed ID: 3819647
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila.
Blander SJ; Horwitz MA
J Clin Invest; 1991 Mar; 87(3):1054-9. PubMed ID: 1999485
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
Nash TW; Libby DM; Horwitz MA
J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
[TBL] [Abstract][Full Text] [Related]
6. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection.
Yamamoto Y; Klein TW; Newton C; Friedman H
J Immunol; 1992 Jan; 148(2):584-9. PubMed ID: 1729375
[TBL] [Abstract][Full Text] [Related]
7. A live avirulent mutant Legionella pneumophila vaccine induces protective immunity against lethal aerosol challenge.
Blander SJ; Breiman RF; Horwitz MA
J Clin Invest; 1989 Mar; 83(3):810-5. PubMed ID: 2646318
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunity to Legionella pneumophila in guinea pigs assessed by direct and indirect migration inhibition reactions in vitro.
Friedman H; Widen R; Lee I; Klein T
Infect Immun; 1983 Sep; 41(3):1132-7. PubMed ID: 6350180
[TBL] [Abstract][Full Text] [Related]
9. [The protective properties of different Legionella antigens in experimental Legionella infection].
Tartakovskiĭ IS; Zubashev IK; Koniukhov VF; Petrosov VV; Eruslanov BV; Nebozhina LV; Rodionov AV; Dmitriev BA; Suchkov IuG; Pronin AV
Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):81-5. PubMed ID: 2386005
[TBL] [Abstract][Full Text] [Related]
10. Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures.
Yamamoto Y; Klein TW; Newton CA; Widen R; Friedman H
Infect Immun; 1987 Jun; 55(6):1369-74. PubMed ID: 3570468
[TBL] [Abstract][Full Text] [Related]
11. A comparison of virulence of two strains of Legionella pneumophila based on experimental aerosol infection of guinea-pigs.
Jepras RI; Fitzgeorge RB; Baskerville A
J Hyg (Lond); 1985 Aug; 95(1):29-38. PubMed ID: 4020112
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against Legionella pneumophila: serum antibody correlates with protection induced by heat-killed or acetone-killed cells against intraperitoneal but not aerosol infection in guinea pigs.
Eisenstein TK; Tamada R; Meissler J; Flesher A; Oels HC
Infect Immun; 1984 Sep; 45(3):685-91. PubMed ID: 6469355
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
[TBL] [Abstract][Full Text] [Related]
15. The course of Legionella pneumonia in guinea pigs after inhalation of various quantities of L. pneumophila.
Twisk-Meijssen MJ; Meenhorst PL; van Cronenburg BJ; Mulder JD; Scheffer E; van Furth R
Immunobiology; 1987 Dec; 176(1-2):108-24. PubMed ID: 3447980
[TBL] [Abstract][Full Text] [Related]
16. Legionella pneumophila pathogenesis and immunity.
Friedman H; Yamamoto Y; Klein TW
Semin Pediatr Infect Dis; 2002 Oct; 13(4):273-9. PubMed ID: 12491233
[TBL] [Abstract][Full Text] [Related]
17. Fate of Legionella pneumophila Philadelphia-1 strain in resident, elicited, activated, and immune peritoneal macrophages of guinea pigs.
Yoshida S; Mizuguchi Y; Nikaido Y; Mitsuyama M; Nomoto K
Infect Immun; 1987 Oct; 55(10):2477-82. PubMed ID: 3308708
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with the major secretory protein of Legionella induces humoral and cell-mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella.
Blander SJ; Horwitz MA
J Immunol; 1991 Jul; 147(1):285-91. PubMed ID: 1711078
[TBL] [Abstract][Full Text] [Related]
19. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
Edelstein PH; Shinzato T; Edelstein MA
J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
[TBL] [Abstract][Full Text] [Related]
20. Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats.
Davis GS; Winn WC; Gump DW; Craighead JE; Beaty HN
Am Rev Respir Dis; 1982 Dec; 126(6):1050-7. PubMed ID: 6983846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
